Pulse lineResearch With Heart Logo

ARIC Publications

Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Selvin E, Rawlings A, Lutsey PL, Maruthur N, Pankow JS, Steffes M. "Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality." Diabetes. 2016;65(1):201-8.
Selvin E, Rawlings AM, Grams M, Klein R, Steffes M. "Association of 1,5-anhydroglucitol with diabetes and microvascular conditions." Clin Chem. 2014;60(11):1409-18.
Selvin E, Wang D, Tang O, Minotti M, Echouffo-Tcheugui JB, Coresh J. "Glucose Patterns in Very Old Adults: A Pilot Study in a Community-Based Population." Diabetes Technol Ther. 2021.
Selvin E, Ning Y, Steffes MW, et al. "Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes." Diabetes. 2011;60(1):298-305.
Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. "Racial differences in glycemic markers: a cross-sectional analysis of community-based data." Ann Intern Med. 2011;154(5):303-9.
Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. "Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study." Arch Intern Med. 2005;165(16):1910-6.
Selvin E, Wattanakit K, Steffes MW, Coresh J, A Sharrett R. "HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study." Diabetes Care. 2006;29(4):877-82.
Selvin E, Rawlings AM, Lutsey PL, Maruthur N, Pankow JS, Steffes M. "Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death." Circulation. 2015;132(4):269-77.
Selvin E, Rawlings AM, Grams M, Klein R, Sharrett ARichey, Steffes M. "Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study." Lancet Diabetes Endocrinol. 2014;2(4):279-288.
Selvin E, Francis LMA, Ballantyne CM, et al. "Nontraditional markers of glycemia: associations with microvascular conditions." Diabetes Care. 2011;34(4):960-7.
Selvin E, Warren B, He X, Sacks DB. "Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol." Clin Chem. 2018;64(5):843-850.
Selvin E, Lazo M, Chen Y, et al. "Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage." Circulation. 2014;130(16):1374-82.
Selvin E, Coresh J, Zhu H, Folsom A, Steffes MW. "Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study." J Diabetes. 2010;2(2):118-24.
Selvin E, Coresh J, Jordahl J, Boland L, Steffes MW. "Stability of haemoglobin A1c (HbA1c) measurements from frozen whole blood samples stored for over a decade." Diabet Med. 2005;22(12):1726-30.
Selvin E, Wang D, Matsushita K, Grams ME. "Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes: A Prospective Cohort Study." Ann Intern Med. 2018;169(3):156-164.
Selvin E, Rawlings AM, Bergenstal RM, Coresh JJ. "No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes." Diabetes Care. 2013;36(10):2995-3001.
Selvin E, Coresh J, Shahar E, Zhang L, Steffes M, A Sharrett R. "Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study." Lancet Neurol. 2005;4(12):821-6.
"Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference." Diabetes Care. 2016;39(8):1462-7.
Selvin E, Steffes MW, Zhu H, et al. "Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults." N Engl J Med. 2010;362(9):800-11.
Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW. "Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study." Diabetes Care. 2005;28(8):1965-73.
Selvin E, Halushka MK, Rawlings AM, Hoogeveen RC, Ballantyne CM, Coresh JJ. "sRAGE and risk of diabetes, cardiovascular disease, and death." Diabetes. 2013;62(6):2116-21.
Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. "Performance of A1C for the classification and prediction of diabetes." Diabetes Care. 2011;34(1):84-9.
Selvaraj S, Seidelmann S, Silvestre OM, et al. "HFE H63D Polymorphism and the Risk for Systemic Hypertension, Myocardial Remodeling, and Adverse Cardiovascular Events in the ARIC Study." Hypertension. 2019;73(1):68-74.
Selvaraj S, Myhre PL, Vaduganathan M, et al. "Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community." JACC Heart Fail. 2020;8(8):640-653.
Selvaraj S, Claggett B, Minamisawa M, et al. "Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans." J Am Coll Cardiol. 2021;78(1):89-91.
Sekula P, Tin A, Schultheiss UT, et al. "Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease." Sci Rep. 2020;10(1):10018.
Seidelmann SB, Feofanova E, Yu B, et al. "Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk." J Am Coll Cardiol. 2018;72(15):1763-1773.
Seidelmann SB, Vardeny O, Claggett B, et al. "An Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality." J Am Heart Assoc. 2017;6(4).
Seidelmann SB, Claggett B, Cheng S, et al. "Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis." Lancet Public Health. 2018;3(9):e419-e428.
Seidelmann SB, Claggett B, Bravo PE, et al. "Retinal Vessel Calibers in Predicting Long-Term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study." Circulation. 2016;134(18):1328-1338.
Segar MW, Jaeger BC, Patel KV, et al. "Development and Validation of Machine Learning-Based Race-Specific Models to Predict 10-Year Risk of Heart Failure: A Multicohort Analysis." Circulation. 2021;143(24):2370-2383.
Secora A, G Alexander C, Ballew SH, Coresh JJ. "Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults." Drugs Aging. 2018;35(8):735-750.
Seaman CD, George KM, Ragni M. "Association of von Willebrand factor deficiency with prevalent cardiovascular disease and asymptomatic carotid atherosclerosis: The Atherosclerosis Risk in Communities Study." Thromb Res. 2016;144:236-8.
Scott RA, Lagou V, Welch RP, et al. "Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways." Nat Genet. 2012;44(9):991-1005.
Scott RA, Scott LJ, Mägi R, et al. "An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans." Diabetes. 2017;66(11):2888-2902.
Scott RA, Freitag DF, Li L, et al. "A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease." Sci Transl Med. 2016;8(341):341ra76.
Scott RA, Chu AY, Grarup N, et al. "No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels." Diabetes. 2012;61(5):1291-6.
"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions." Eur Heart J. 2021;42(25):2455-2467.
"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe." Eur Heart J. 2021;42(25):2439-2454.
Schwartz SW, Carlucci C, Chambless LE, Rosamond WD. "Synergism between smoking and vital exhaustion in the risk of ischemic stroke: evidence from the ARIC study." Ann Epidemiol. 2004;14(6):416-24.
Schunk SJ, Kleber ME, März W, et al. "Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality." Eur Heart J. 2021;42(18):1742-1756.
Schultheiss UT, Daya N, Grams ME, et al. "Thyroid function, reduced kidney function and incident chronic kidney disease in a community-based population: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2017;32(11):1874-1881.
Schultheiss UT, Teumer A, Medici M, et al. "A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations." J Clin Endocrinol Metab. 2015;100(5):E799-807.
Schroeder EB, Welch V L, Evans GW, Heiss G. "Impaired lung function and subclinical atherosclerosis. The ARIC Study." Atherosclerosis. 2005;180(2):367-73.
Schroeder EB, Welch V L, Couper D, et al. "Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2003;158(12):1171-81.
Schroeder EB, Chambless LE, Liao D, et al. "Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study." Diabetes Care. 2005;28(3):668-74.
Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. "Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study." Hypertension. 2003;42(6):1106-11.
Schroeder EB, Whitsel EA, Evans GW, Prineas RJ, Chambless LE, Heiss G. "Repeatability of heart rate variability measures." J Electrocardiol. 2004;37(3):163-72.
Schreiner PJ, Wu KK, M Malinow R, et al. "Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study." Ann Epidemiol. 2002;12(4):228-36.
Schreiner PJ, Appiah D. "Gamma prime (γ') fibrinogen and carotid intima-media thickness: the Atherosclerosis Risk in Communities study." Blood Coagul Fibrinolysis. 2017;28(8):665-669.
Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR, Heiss G. "Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study." Am J Epidemiol. 1996;144(4):335-45.
Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R. "Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 1996;16(3):471-8.
Schreiner PJ, Chambless LE, Brown SA, Watson RL, Toole J, Heiss G. "Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities." Ann Epidemiol. 1994;4(5):351-9.
Schreiner PJ. "Lipoprotein(a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study." Chem Phys Lipids. 1994;67-68:405-10.
Schreiner PJ, Morrisett JD, Sharrett AR, et al. "Lipoprotein[a] as a risk factor for preclinical atherosclerosis." Arterioscler Thromb. 1993;13(6):826-33.
Schneider ALC, Selvin E, Sharrett ARichey, et al. "Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS)." Diabetes Care. 2017;40(11):1514-1521.
Schneider ALC, Sharrett ARichey, Patel MD, et al. "Education and cognitive change over 15 years: the atherosclerosis risk in communities study." J Am Geriatr Soc. 2012;60(10):1847-53.
Schneider ALC, Zhao D, Lutsey PL, et al. "Serum Vitamin D Concentrations and Cognitive Change Over 20 Years: The Atherosclerosis Risk in Communities Neurocognitive Study." Neuroepidemiology. 2018;51(3-4):131-137.
Schneider ALC, Williams EK, Brancati FL, Blecker S, Coresh JJ. "Diabetes and risk of fracture-related hospitalization: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2013;36(5):1153-8.
Schneider ALC, Jonassaint C, Sharrett ARichey, et al. "Hemoglobin, Anemia, and Cognitive Function: The Atherosclerosis Risk in Communities Study." J Gerontol A Biol Sci Med Sci. 2016;71(6):772-9.
Schneider ALC, Wang D, Gottesman RF, Selvin E. "Prevalence of Disability Associated With Head Injury With Loss of Consciousness in Adults in the United States: A Population-Based Study." Neurology. 2021;97(2):e124-e135.
Schneider ALC, Lutsey PL, Alonso A, et al. "Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study." Eur J Neurol. 2014;21(9):1211-8, e69-70.
Schneider ALC, Lazo M, Ndumele CE, Pankow JS, Coresh JJ, Clark JM. "Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study." Diabet Med. 2013;30(8):926-33.
Schneider ALC, Kalyani RR, Golden S, et al. "Diabetes and Prediabetes and Risk of Hospitalization: The Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2016;39(5):772-9.
Schneider ALC, Gottesman RF, Mosley T, et al. "Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study." Neuroepidemiology. 2013;40(2):117-24.
Schneider ALC, Senjem ML, Wu A, et al. "Neural correlates of domain-specific cognitive decline: The ARIC-NCS Study." Neurology. 2019;92(10):e1051-e1063.
Schneider ALC, Lutsey PL, Selvin E, et al. "Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study." Eur J Neurol. 2015;22(8):1220-7.
Schneider ALC, Rawlings AM, Sharrett ARichey, et al. "High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study." Eur Heart J. 2014;35(27):1817-24.
Schneider ALC, Sharrett ARichey, Gottesman RF, et al. "Normative data for 8 neuropsychological tests in older blacks and whites from the atherosclerosis risk in communities (ARIC) study." Alzheimer Dis Assoc Disord. 2015;29(1):32-44.
Schneider ALC, Pankow JS, Heiss G. "Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2012;176(8):738-43.
Schneider ALC, Selvin E, Latour L, et al. "Head injury and 25-year risk of dementia." Alzheimers Dement. 2021.
Schneider ALC, Selvin E, Liang M, et al. "Association of Head Injury with Brain Amyloid Deposition: The ARIC-PET Study." J Neurotrauma. 2019;36(17):2549-2557.
Schmitz KH, Arnett DK, Bank A, et al. "Arterial distensibility and physical activity in the ARIC study." Med Sci Sports Exerc. 2001;33(12):2065-71.
Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. "A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study." Diabetes Care. 1996;19(5):414-8.
Schmidt MI, Watson RL, Duncan BB, et al. "Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators." Metabolism. 1996;45(6):699-706.
Schmidt M I, Duncan BB, Vigo A, et al. "Detection of undiagnosed diabetes and other hyperglycemia states: the Atherosclerosis Risk in Communities Study." Diabetes Care. 2003;26(5):1338-43.
Schmidt MI, Duncan BB, Sharrett AR, et al. "Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study." Lancet. 1999;353(9165):1649-52.
Schmidt M I, Duncan BB, Bang H, et al. "Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study." Diabetes Care. 2005;28(8):2013-8.
Schmidt MI, Duncan BB, Vigo A, et al. "Leptin and incident type 2 diabetes: risk or protection?" Diabetologia. 2006;49(9):2086-96.
Schick UM, Auer PL, Bis JC, et al. "Association of exome sequences with plasma C-reactive protein levels in >9000 participants." Hum Mol Genet. 2015;24(2):559-71.

Pages